Skip to main content
. 2017 Jun 28;9(18):797–807. doi: 10.4254/wjh.v9.i18.797

Table 1.

Doxorubicin as first line treatment in hepatocellular carcinoma

Ref. n Line/treatment Relevant data
Nagahama et al[21] 147 First line doxorubicin Severe cirrhosis, PS 2-3, tumour occupying > 50% liver do not respond to chemo
Olweny et al[22] 14 First line doxorubicin RR 79%
Sciarrino et al[23] First line doxorubicin RR 10%-20%
Chlebowski et al[24]

RR: Response rate.